Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium

NCT00101608 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Transitional Cell Carcinoma
Bladder Neoplasms
Kidney Neoplasms
Ureter Neoplasms
Bladder Cancer
Neoplasm, Bladder

Interventions

DRUG: vinflunine

Sponsor

Bristol-Myers Squibb

Collaborators

[object Object]